DelMar Pharmaceuticals, Inc. 4
4 · DelMar Pharmaceuticals, Inc. · Filed Jul 11, 2017
Insider Transaction Report
Form 4
Cranston Lynda Sarah
Director
Transactions
- Award
Options (Right to Buy)
2017-07-07+36,000→ 36,000 totalExercise: $2.11From: 2020-06-30Exp: 2027-07-07→ Common Stock (36,000 underlying) - Award
Performance Stock Units
2017-07-07+200,000→ 200,000 totalExp: 2022-07-07→ Common Stock (200,000 underlying)
Footnotes (2)
- [F1]12,000 options vest on June 30, 2018, and 3,000 options vest each three months thereafter starting September 30, 2018.
- [F2]Subject to stockholder approval of the Company's 2017 Omnibus Equity Incentive Plan at the Company's annual meeting, each performance stock unit represents the right to receive one share of common stock upon vesting of the unit based on achievement of specified targets related to the Company's financial performance.